Published in PLOS Biology · View the paper (DOI)
A study by researchers at the University of Michigan found that an extra copy of the DSCAM gene in mice with Down syndrome causes improper neuron development and excessive inhibition. This discovery suggests modulation of DSCAM expression levels could be a viable therapeutic strategy for repairing synaptic deficits seen in Down syndrome.
Coverage from 2 institutions